| 产品名称: | Blastomyces dermatitidis Gilchrist et Stokes |
|---|---|
| 商品货号: | TS194865 |
| Strain Designations: | A2 |
| Alternate State: | Ajellomyces dermatitidis McDonough et Lewis |
| Application: | Biomedical Research and Development Material Emerging infectious disease research |
| Biosafety Level: | 3
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format: | frozen |
| Storage Conditions: | Frozen: -80°C or colder Freeze-Dried: 2°C to 8°C Live Culture: See Propagation Section |
| Type Strain: | no |
| Preceptrol®: | no |
| Comments: | characterization |
| Medium: | ATCC® Medium 28: Emmons modification of Sabourauds agar ATCC® Medium 44: Brain Heart Infusion Agar/Broth ATCC® Medium 336: Potato dextrose agar (PDA) |
| Growth Conditions: | Temperature: 37°C Atmosphere: Typical aerobic |
| Sequenced Data: | No DNA sequencing was performed in house on this product.
|
| Name of Depositor: | DA Stevens |
| Chain of Custody: | ATCC |
| Isolation: | Attenuated mutant derived from ATCC® 26199™ |
| References: | Hogan LH, Klein BS. Transforming DNA integrates at multiple sites in the dimorphic fungal pathogen Blastomyces dermatitidis. Gene 186: 219-226, 1997. PubMed: 9074500 Morrison CJ, et al. In vitro fungicidal activity of murine polymorphonuclear neutrophils (PMN) correlates with in vivo virulence of Blastomyces dermatitidis (BD) strains. Clin. Res. 34: 677A, 1986. |